MML Investors Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.6M Sell
10,787
-6
-0.1% -$1.45K 0.01% 1120
2025
Q1
$2.63M Buy
10,793
+133
+1% +$32.4K 0.01% 1036
2024
Q4
$3.5M Buy
10,660
+5,299
+99% +$1.74M 0.01% 857
2024
Q3
$1.79M Buy
5,361
+159
+3% +$53.2K 0.01% 1151
2024
Q2
$1.42M Sell
5,202
-2,362
-31% -$645K 0.01% 1205
2024
Q1
$2.62M Buy
7,564
+1,290
+21% +$446K 0.01% 921
2023
Q4
$2.03M Sell
6,274
-3,811
-38% -$1.23M 0.01% 985
2023
Q3
$3.62M Sell
10,085
-282
-3% -$101K 0.02% 665
2023
Q2
$3.93M Buy
+10,367
New +$3.93M 0.02% 629
2023
Q1
Sell
-8,487
Closed -$3.57M 2093
2022
Q4
$3.57M Buy
8,487
+528
+7% +$222K 0.02% 613
2022
Q3
$3.32M Buy
7,959
+944
+13% +$394K 0.03% 568
2022
Q2
$3.47M Buy
7,015
+590
+9% +$292K 0.03% 537
2022
Q1
$3.62M Buy
6,425
+600
+10% +$338K 0.03% 552
2021
Q4
$4.4M Buy
5,825
+872
+18% +$659K 0.03% 480
2021
Q3
$3.7M Buy
4,953
+520
+12% +$388K 0.03% 508
2021
Q2
$2.86M Buy
4,433
+512
+13% +$330K 0.02% 574
2021
Q1
$2.24M Buy
3,921
+852
+28% +$487K 0.02% 614
2020
Q4
$1.79M Buy
3,069
+182
+6% +$106K 0.02% 628
2020
Q3
$1.49M Buy
2,887
+32
+1% +$16.5K 0.02% 631
2020
Q2
$1.29M Buy
2,855
+1,082
+61% +$489K 0.02% 635
2020
Q1
$622K Buy
1,773
+481
+37% +$169K 0.01% 782
2019
Q4
$478K Buy
1,292
+434
+51% +$161K 0.01% 1024
2019
Q3
$285K Buy
858
+83
+11% +$27.6K ﹤0.01% 1216
2019
Q2
$242K Buy
775
+72
+10% +$22.5K ﹤0.01% 1406
2019
Q1
$215K Buy
+703
New +$215K ﹤0.01% 1450